Browse > Home / Health / FDA Orders Amgen To Make Changes To Label Of Anemia Drug

FDA Orders Amgen To Make Changes To Label Of Anemia Drug

July 31, 2008

The U.S. Food and Drug Administration (FDA) has told Amgen Inc. that they need to make changes to the label of their anemia drug, Aranesp......Washington (ChattahBox) - The U.S. Food and Drug Administration (FDA) has told Amgen Inc. that they need to make changes to the label of their anemia drug, Aranesp.

The FDA is ordering changes to be made to the drug from Amgen Inc., as well as similar anemia drugs.

This comes after the revelation that they can pose a risk to cancer patients.

The FDA wants the labels revised, and made to state that the drugs are not meant for cancer patients who are going through chemotherapy.

Also, they must add that people with hemoglobin levels greater than, or equal to, 10 grams per deciliter, should not take the drug.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists

Written by admin · Filed Under Health 


Comments

Got something to say?